Area of research
Critical Care and Intensive Care Medicine · Molecular Medicine
Research interest
Research focused on Procalcitonin and Intensive care medicine, with related work in Imipenem, Ceftazidime/avibactam, Ticarcillin. Notable publications include 'Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections', 'Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis', and 'Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)'.
Cloxacillin versus cefazolin for meticillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): a prospective, open-label, multicentre, non-inferiority, randomised clinical trial
Herpes Simplex Virus Encephalitis With Initial Negative Polymerase Chain Reaction in the Cerebrospinal Fluid: Prevalence, Associated Factors, and Clinical Impact*
Cerebrovascular complications and outcomes of critically ill adult patients with infective endocarditis
Assessment of Magnetic Resonance Imaging Changes and Functional Outcomes Among Adults With Severe Herpes Simplex Encephalitis
Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients
Management of acute community-acquired bacterial meningitis (excluding newborns). Long version with arguments
Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation
Functional outcomes in adult patients with herpes simplex encephalitis admitted to the ICU: a multicenter cohort study
Management of oral antiretroviral administration in patients with swallowing disorders or with an enteral feeding tube
Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials
Functional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study
Primary bacterial ventriculitis in adults, an emergent diagnosis challenge: report of a meningoccal case and review of the literature
Efficacy of cloxacillin versus cefazolin for methicillin-susceptible <i>Staphylococcus aureus</i> bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis—The ESCAPE Study
Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review
Outbreak of Pneumocystis jirovecii Infection Among Heart Transplant Recipients: Molecular Investigation and Management of an Interhuman Transmission
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, <i>Candida</i> Colonization, and Multiple Organ Failure
Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation
Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective
Prognostic value of procalcitonin in respiratory tract infections across clinical settings
Sternal Wound Infection after Cardiac Surgery: Management and Outcome
Corrigendum to ‘Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams’ [Clin Microbiol Infec 21 (2015) 649.e1–649.e10]
Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)